AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

March 2, 2020 GMT

BRISBANE, Calif.--(BUSINESS WIRE)--Mar 2, 2020--

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences:

  • Cowen 40 th Annual Health Care Conference
    Presentation Date: Wednesday, March 4 th at 10:00 a.m. Eastern Time
    Location: Boston, MA

  • Barclays Global Healthcare Conference
    Presentation Date: Wednesday, March 11 th at 8:30 a.m. Eastern Time
    Location: Miami, FL

Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will also be available on the Sangamo website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200302005338/en/

CONTACT: Investor Relations – Global

McDavid Stilwell

510-970-6000, x219

mstilwell@sangamo.comMedia Inquiries – Global

Aron Feingold

510-970-6000, x421

afeingold@sangamo.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS CALIFORNIA FLORIDA

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL GENETICS HEALTH

SOURCE: Sangamo Therapeutics, Inc.

Copyright Business Wire 2020.

PUB: 03/02/2020 08:30 AM/DISC: 03/02/2020 08:30 AM

http://www.businesswire.com/news/home/20200302005338/en